SESSION TITLE: Pneumonia Diagnosis and Outcomes
SESSION TYPE: Original Investigation Slide
PRESENTED ON: Wednesday, October 26, 2016 at 02:45 PM - 04:15 PM
PURPOSE: Our study aims at finding microbial etiology, antibiotic susceptibility and clinical outcomes of HCAP.
METHODS: ATS/IDSA criteria were used for including patients in two groups - HCAP and HAP. Total 318 patients meeting criteria (Excluding CAP), were grouped in HCAP - 165 cases (52%) and HAP (including VAP) - 153 controls (48%). Microbiological investigations: Sputum and Endo - tracheal aspirate (ETA) cultures were done using Blood agar, MacConkey agar and Chocolate agar. BacT/ALERT® 3D automated system was used for blood cultures. Antibiotic susceptibility testing of isolates from sputum and ETA was done by Kirby and Bauer Disc Diffusion method as per Clinical Laboratory Standard Institute (CLSI) guidelines. Antibiotic susceptibility testing of isolates from blood was done on VITEK 2.